GB0708136D0 - Measure of contrast agent - Google Patents
Measure of contrast agentInfo
- Publication number
- GB0708136D0 GB0708136D0 GBGB0708136.7A GB0708136A GB0708136D0 GB 0708136 D0 GB0708136 D0 GB 0708136D0 GB 0708136 A GB0708136 A GB 0708136A GB 0708136 D0 GB0708136 D0 GB 0708136D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- measure
- contrast agent
- function
- bolus
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/026—Measuring blood flow
- A61B5/0263—Measuring blood flow using NMR
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/415—Evaluating particular organs or parts of the immune or lymphatic systems the glands, e.g. tonsils, adenoids or thymus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/418—Evaluating particular organs or parts of the immune or lymphatic systems lymph vessels, ducts or nodes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/563—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution of moving material, e.g. flow contrast angiography
- G01R33/56366—Perfusion imaging
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T7/00—Image analysis
- G06T7/0002—Inspection of images, e.g. flaw detection
- G06T7/0012—Biomedical image inspection
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/10—Image acquisition modality
- G06T2207/10072—Tomographic images
- G06T2207/10076—4D tomography; Time-sequential 3D tomography
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/10—Image acquisition modality
- G06T2207/10072—Tomographic images
- G06T2207/10088—Magnetic resonance imaging [MRI]
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/30—Subject of image; Context of image processing
- G06T2207/30004—Biomedical image processing
- G06T2207/30101—Blood vessel; Artery; Vein; Vascular
- G06T2207/30104—Vascular flow; Blood flow; Perfusion
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H30/00—ICT specially adapted for the handling or processing of medical images
- G16H30/20—ICT specially adapted for the handling or processing of medical images for handling medical images, e.g. DICOM, HL7 or PACS
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H30/00—ICT specially adapted for the handling or processing of medical images
- G16H30/40—ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
Landscapes
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Physics & Mathematics (AREA)
- Radiology & Medical Imaging (AREA)
- Medical Informatics (AREA)
- Biomedical Technology (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Veterinary Medicine (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- High Energy & Nuclear Physics (AREA)
- Heart & Thoracic Surgery (AREA)
- Signal Processing (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Physiology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Quality & Reliability (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Theoretical Computer Science (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Abstract
A vascular input function, to estimate a measure of contrast agent concentration, which is decomposed into a function component representing the bolus of contrast-enhancing agent and a function component representing equilibration of the bolus by leakage from the circulatory system of the subject in to other parts of the body of the subject (referred to as the "body transfer function"). Restricting the components to suitable analytical (e.g. algebraic) mathematical functions ensures that the calculations can be carried out analytically.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0708136.7A GB0708136D0 (en) | 2007-04-26 | 2007-04-26 | Measure of contrast agent |
PCT/GB2008/001476 WO2008132469A1 (en) | 2007-04-26 | 2008-04-25 | Estimation of a measure of contrast agent concentration using an analytical mathematical model |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0708136.7A GB0708136D0 (en) | 2007-04-26 | 2007-04-26 | Measure of contrast agent |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0708136D0 true GB0708136D0 (en) | 2007-06-06 |
Family
ID=38170762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0708136.7A Ceased GB0708136D0 (en) | 2007-04-26 | 2007-04-26 | Measure of contrast agent |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0708136D0 (en) |
WO (1) | WO2008132469A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111613300B (en) * | 2019-02-22 | 2023-09-15 | 曹生 | Tumor and blood vessel Ai processing method and product based on VRDS 4D medical image |
CN111613301B (en) * | 2019-02-22 | 2023-09-15 | 曹生 | Arterial and venous Ai processing method and product based on VRDS 4D medical image |
DE102019207639A1 (en) * | 2019-05-24 | 2020-11-26 | Siemens Healthcare Gmbh | Improved calculation of the contrast agent concentration |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005106517A2 (en) * | 2004-05-04 | 2005-11-10 | Stiftelsen Universitetsforskning Bergen | Blind determination of the arterial input and tissue residue functions in perfusion mri |
-
2007
- 2007-04-26 GB GBGB0708136.7A patent/GB0708136D0/en not_active Ceased
-
2008
- 2008-04-25 WO PCT/GB2008/001476 patent/WO2008132469A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2008132469A1 (en) | 2008-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY151150A (en) | Syringe with recessed nose for use with frontal attachments | |
MX2009011898A (en) | Compositions and methods for treating disorders associated with salt or fluid retention. | |
NZ604063A (en) | Compositions and methods for enhancing physiological performance and recovery time | |
MX352627B (en) | Emulsion stabilizing agents for drilling and completion fluids. | |
UA113849C2 (en) | THE APPLICATION OF SIGMA LIGANDS IN TYPE 2 PATIENTS WITH PAIN | |
WO2007103373A3 (en) | Compositions and methods for the treatment of immunoinflammatory disorders | |
WO2011132122A3 (en) | Blood reservoir with ultrasonic volume sensor | |
GB0708136D0 (en) | Measure of contrast agent | |
MA34815B1 (en) | COMPOSITIONS COMPRISING A PI3K INHIBITOR AND A MEK INHIBITOR AND THEIR USE FOR THE TREATMENT OF CANCER | |
WO2007143682A3 (en) | Systems and methods of delivering fluids to a patient of varying concentration | |
WO2009022988A3 (en) | Vhz for diagnosis and treatment of cancer | |
WO2014004674A3 (en) | Combination treatment of abt-450 and ritonavir and e.g. abt-072 and/or abt-333|for use in treating hcv | |
PH12015500709A1 (en) | Skin cleansing agent composition | |
UA93581C2 (en) | Agent containing G-CSF for preventing and treating diabetic peripheral neuropathy | |
WO2007026265A3 (en) | Use of enoxaparin for performimg percutaneous coronary intervention | |
WO2009004189A9 (en) | Method for measuring the plasmine activity of microparticles present in a sample of a biological fluid and use thereof | |
Liverman | Careful with that planet, Mr President. | |
UA29608U (en) | Method for early detection of macular edema in case of diabetic retinopathy | |
Razumnikova | Manifestations of gender differences in creative activity | |
Voiculescu | Aspects of the influence of subjective factors in school assessment | |
Murray | Zoè | |
伊藤優一郎 | Z4 Repository | |
Devarakonda | Brentuximab vedotin | |
Gosteva | INTEGRATED EXECUTION ESTIMATION OF PROJECTS AT THE ENTERPRISES IN THE SPACE-ROCKET BRANCH | |
Zhang et al. | Method of machinery fault diagnosis based on variable precision rough set. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |